1.33
price down icon2.21%   -0.03
after-market Dopo l'orario di chiusura: 1.30 -0.03 -2.26%
loading
Precedente Chiudi:
$1.36
Aprire:
$1.35
Volume 24 ore:
418.84K
Relative Volume:
0.11
Capitalizzazione di mercato:
$42.93M
Reddito:
-
Utile/perdita netta:
$-16.14M
Rapporto P/E:
-2.463
EPS:
-0.54
Flusso di cassa netto:
$-3.99M
1 W Prestazione:
+8.13%
1M Prestazione:
-10.74%
6M Prestazione:
-70.96%
1 anno Prestazione:
-78.09%
Intervallo 1D:
Value
$1.30
$1.36
Intervallo di 1 settimana:
Value
$1.22
$1.45
Portata 52W:
Value
$1.12
$8.40

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name
Nome
Telomir Pharmaceuticals Inc
Name
Telefono
786-396-6723
Name
Indirizzo
100 SE 2ND ST, MIAMI
Name
Dipendente
5
Name
Cinguettio
Name
Prossima data di guadagno
2025-09-03
Name
Ultimi documenti SEC
Name
TELO's Discussions on Twitter

Confronta TELO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TELO
Telomir Pharmaceuticals Inc
1.33 46.01M 0 -16.14M -3.99M -0.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
393.21 101.15B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
461.14 61.07B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.59 59.35B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
756.83 46.29B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
332.27 35.69B 3.81B -644.79M -669.77M -6.24

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-21 Iniziato Rodman & Renshaw Buy

Telomir Pharmaceuticals Inc Borsa (TELO) Ultime notizie

pulisher
12:31 PM

Analyzing recovery setups for Telomir Pharmaceuticals Inc. investorsMarket Growth Report & Community Consensus Picks - newser.com

12:31 PM
pulisher
Sep 15, 2025

Exit strategy if you’re trapped in Telomir Pharmaceuticals Inc.2025 Short Interest & Community Verified Trade Signals - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

How moving averages guide Telomir Pharmaceuticals Inc. tradingQuarterly Risk Review & Free Expert Verified Stock Movement Alerts - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Bearish Setup: Will Telomir Pharmaceuticals Inc outperform small cap indexesJuly 2025 Final Week & Real-Time Stock Movement Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

How to build a custom watchlist for Telomir Pharmaceuticals Inc.July 2025 Setups & Free Accurate Trade Setup Notifications - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Price momentum metrics for Telomir Pharmaceuticals Inc. explainedJuly 2025 Sector Moves & Safe Entry Point Alerts - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Dow Update: What is the long term forecast for Telomir Pharmaceuticals Inc. stock2025 Key Highlights & AI Powered Market Entry Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases - The Marion Star

Sep 15, 2025
pulisher
Sep 15, 2025

Quantitative breakdown of Telomir Pharmaceuticals Inc. recent moveMarket Trend Report & AI Driven Price Forecasts - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Trading Recap: Is BBSI a defensive stock2025 Stock Rankings & Long Hold Capital Preservation Tips - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Can momentum traders help lift Telomir Pharmaceuticals Inc.Trade Analysis Report & Expert Verified Stock Movement Alerts - newser.com

Sep 15, 2025
pulisher
Sep 14, 2025

Can you recover from losses in Telomir Pharmaceuticals Inc.Earnings Miss & Low Drawdown Trading Techniques - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Predicting Telomir Pharmaceuticals Inc. trend using moving averages2025 Top Decliners & Free Low Drawdown Momentum Trade Ideas - newser.com

Sep 14, 2025
pulisher
Sep 12, 2025

Telomir Pharmaceuticals Stock Price, Quotes and Forecasts - Benzinga

Sep 12, 2025
pulisher
Sep 12, 2025

What high frequency data says about Telomir Pharmaceuticals Inc.2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Telomir Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Backtesting results for Telomir Pharmaceuticals Inc. trading strategiesGap Up & Community Consensus Trade Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Short interest data insights for Telomir Pharmaceuticals Inc.Weekly Profit Report & Fast Moving Market Watchlists - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Analyzing net buyer seller activity in Telomir Pharmaceuticals Inc.Rate Cut & Long-Term Capital Growth Strategies - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Published on: 2025-09-12 05:33:48 - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Earnings visualization tools for Telomir Pharmaceuticals Inc.2025 Support & Resistance & High Conviction Buy Zone Picks - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

How high can Telomir Pharmaceuticals Inc. stock goTrade Analysis Summary & Real-Time Price Movement Reports - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Chart based exit strategy for Telomir Pharmaceuticals Inc.Portfolio Return Summary & Low Risk Growth Stock Ideas - Newser

Sep 12, 2025
pulisher
Sep 11, 2025

Volume spikes in Telomir Pharmaceuticals Inc. stock – what they meanJuly 2025 Closing Moves & Accurate Technical Buy Alerts - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy - The Florida Times-Union

Sep 11, 2025
pulisher
Sep 09, 2025

Telomir’s drug candidate shows promise in reversing cancer gene silencing By Investing.com - Investing.com Nigeria

Sep 09, 2025
pulisher
Sep 09, 2025

Telomir’s drug candidate shows promise in reversing cancer gene silencing - Investing.com

Sep 09, 2025
pulisher
Sep 09, 2025

Telomir Pharmaceuticals IncTelomir-1 reverses Cdkn2a gene silencingSEC filing - MarketScreener

Sep 09, 2025
pulisher
Sep 09, 2025

Key resistance and support levels for Telomir Pharmaceuticals Inc.2025 Pullback Review & Stock Portfolio Risk Management - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Published on: 2025-09-09 08:39:23 - beatles.ru

Sep 09, 2025
pulisher
Sep 08, 2025

Published on: 2025-09-09 02:00:19 - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

statistical indicators supporting telomir pharmaceuticals inc.’s strengthQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser

Sep 08, 2025
pulisher
Sep 08, 2025

Detecting support and resistance levels for Telomir Pharmaceuticals Inc.Short Setup & Real-Time Market Trend Scan - Newser

Sep 08, 2025
pulisher
Sep 08, 2025

Telomir Pharmaceuticals Inc. Shows Early Signs of Technical StrengthMarket Sentiment Review & Weekly Momentum Stock Picks - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

How to forecast Telomir Pharmaceuticals Inc. trends using time seriesPortfolio Update Summary & Proven Capital Preservation Methods - Newser

Sep 08, 2025
pulisher
Sep 08, 2025

Using Python tools to backtest Telomir Pharmaceuticals Inc. strategiesJuly 2025 Analyst Calls & Expert Approved Momentum Ideas - Newser

Sep 08, 2025
pulisher
Sep 08, 2025

Is Telomir Pharmaceuticals Inc. stock entering bullish territory2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser

Sep 08, 2025
pulisher
Sep 08, 2025

Is Telomir Pharmaceuticals Inc. still worth holding after the dipEntry Point & Verified Short-Term Plans - Newser

Sep 08, 2025
pulisher
Sep 08, 2025

Will Telomir Pharmaceuticals Inc. stock recover after recent dropQuarterly Market Review & Technical Confirmation Alerts - Newser

Sep 08, 2025
pulisher
Sep 07, 2025

Published on: 2025-09-08 04:15:57 - Newser

Sep 07, 2025
pulisher
Sep 07, 2025

What the charts say about Telomir Pharmaceuticals Inc. todayGold Moves & Fast Exit Strategy with Risk Control - Newser

Sep 07, 2025
pulisher
Sep 07, 2025

Telomir Pharmaceuticals Completes $2.9 Million Stock Sale - MSN

Sep 07, 2025
pulisher
Sep 06, 2025

Automated trading signals detected on Telomir Pharmaceuticals Inc.July 2025 Analyst Calls & Intraday High Probability Setup Alerts - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Is Telomir Pharmaceuticals Inc. a speculative investment2025 Key Lessons & Intraday High Probability Alerts - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Returns Recap: Is Telomir Pharmaceuticals Inc. a cyclical or defensive stockQuarterly Earnings Report & AI Powered Trade Plan Recommendations - خودرو بانک

Sep 06, 2025

Telomir Pharmaceuticals Inc Azioni (TELO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$35.15
price down icon 3.33%
$83.14
price up icon 0.05%
$27.99
price up icon 0.61%
$97.88
price up icon 1.18%
$143.14
price down icon 1.91%
biotechnology ONC
$332.27
price up icon 2.44%
Capitalizzazione:     |  Volume (24 ore):